Ultimovacs acquires Immuneed’s immunotherapy tech business for NOK 50 million

The Norwegian biotech company Ultimovacs took over the immunotherapy technology business of the Swedish company Immuneed AB last month. The complementary technologies of the two companies provide a platform for development of novel vaccine solutions for treatment and possibly prevention of cancer, reports Ultimovacs. The acquired business has been named Ultimovacs AB and is now a … Continue reading Ultimovacs acquires Immuneed’s immunotherapy tech business for NOK 50 million